retatrutide triple agonist obesity phase 2 trial nejm 2023 Research Guide: What the Data Reported (2026) Retatrutide vs Semaglutide: Triple vs – Efficacy and safety of retatrutide,

In adult NHANES (National Health and Nutrition Examination Survey) participants with diagnosed diabetes, glycemic control declined after more than a decade of progress, associated with a resurgence in vascular diabetic complications [23]

Phase 2 trials demonstrated A1C reductions of up to 2.02% in participants with type 2 diabetes, bringing average levels from 8.1% down to 6.08%

Bilal, M

Quick Reference: Loading + Maintenance These figures reflect community-reported protocols, not a recommended schedule

Endocrinology 145(6):26532659 Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R (2002) Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats

Acknowledgements We are indebted to Elita Yuliantie for technical assistance and to Patrick M